WeVote
Log In

Bill

Bill

S 1559

Enacts the "Affordable NY act"

2025 Regular Session Introduced by George Borrello and 8 co-sponsors

Creates MA Special Legislative Commission on Hyperemesis Gravidarum to review coverage, provider training, leave protections, awareness, and research to improve maternal health outcomes.

NOTICE OF COMMITTEE CONSIDERATION - REQUESTED
0
WeVote Research Nonpartisan
Bill Summary · S 1559

Summary — S.1559 (Resolve: “Affordable NY act” / Resolve improving maternal and child health related to Hyperemesis Gravidarum)

Note: the bill text submitted is a Massachusetts legislative resolve creating a special commission to study Hyperemesis Gravidarum (HG). The document identifies State Senator Edward J. Kennedy (by request) as the presenter and a petition of Kevin Gilnack. (Some metadata provided with the request appears inconsistent with the Massachusetts docket; this summary is based on the text of the resolve.)

Purpose

Create a special legislative commission to examine care, support, insurance access, training, research, and state programs related to Hyperemesis Gravidarum (HG) and to produce recommendations for legislative, regulatory, programmatic, and public‑education actions to improve maternal and child health outcomes.

Key provisions

  • Establishes a Special Legislative Commission under Mass. Gen. Laws ch. 4 §2A focused on HG.
  • Commission membership:
    • Co‑chairs: house and senate chairs of the Joint Committee on Public Health.
    • Additional legislative committee chairs and leadership designees, state executive agency designees (e.g., Secretary of Health and Human Services, Commissioner of Public Health), and ~37 appointees by the co‑chairs.
    • Appointees include representatives from advocacy/research/clinical organizations (HER Foundation, AWHONN, nutrition societies, March of Dimes, etc.), clinicians (OB/GYNs, midwives, nurses, PAs), doulas, teaching hospital leaders, medical school faculty, members with lived experience of HG, and two gubernatorial appointees.
    • Appointment requirements emphasize representation from underserved communities and racial/geographic diversity; majority of lay members should reflect communities most impacted by maternal health inequities.
  • Procedural deadlines:
    • Appointments due within 60 days of the act’s effective date.
    • First meeting within 90 days; meet at least quarterly until final report.
    • Authority to hold public hearings, collect testimony, form subcommittees, invite guest/ex‑officio members.
  • Commission duties (explicitly listed):
    1. Audit public and private insurance coverage for HG medications and nutritional therapies; identify barriers and recommend policy/regulatory fixes to ensure affordable access.
    2. Evaluate continuing education and training for mental‑health and maternity providers on HG; recommend expansion strategies.
    3. Review paid‑leave frameworks (Mass. Paid Family & Medical Leave, workers’ comp, disability, sick leave, Pregnant Workers Fairness Act) and recommend policies to ensure leave for debilitating HG without reducing postpartum leave.
    4. Recommend public awareness campaigns for pregnant persons and providers about HG and resources.
    5. Review existing HG research and propose ways to expand study of causes, treatments, and socioeconomic impacts.
    6. Evaluate existing state programs and infrastructure relevant to HG (text truncated in provided version).

Who is affected

  • Pregnant people experiencing HG and their families (including caregivers/fathers).
  • Clinicians and allied providers (OB/GYNs, midwives, nurses, PAs, doulas, mental‑health professionals).
  • Health insurers, employers, state agencies, hospitals, and research institutions.
  • Underserved and racially/ethnically diverse communities disproportionately affected by adverse maternal outcomes.

Procedural status & timeline (as reported)

  • Filed in Massachusetts docket (file date shown 1/17/2025); presented by Senator Edward J. Kennedy (by request).
  • Appointments and first meeting deadlines tied to the act’s effective date (60 and 90 days respectively).
  • Report schedule: commission to meet at least quarterly until issuing final recommendations (no report deadline specified in the truncated text).
  • Metadata notes hearings and referrals (e.g., hearing scheduled 07/10/2025); consult official legislative clerk for current status.

Potential impact

If implemented, the commission’s recommendations could lead to changes in insurance coverage for HG treatments, expanded provider education, improved leave protections for pregnant workers with HG, increased public awareness, and targeted research funding — all aimed at improving maternal and child health outcomes for people affected by severe pregnancy sickness.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.